Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

MERCK AND COMPANY (MRK)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE
Sector news Pharmaceuticals - NEC
02:04aASTRAZENECA : ceo warns of medicine shortages after Brexit - Sunday Times
RE
09/22J&J UNIT : Esketamine Study Didn't Show Statistical Significance for Primary End..
DJ
09/21JOHNSON & JOHNSON : J&J Unit Agrees To Sell Sterilization Unit for $2.7 Billion
DJ
09/21EMA Nod to Eli Lilly Drug Stokes Competition in Migraine Prevention Market
DJ
09/21Triple Set of EMA Recommendations for Novartis Drugs
DJ
09/21GlaxoSmithKline, Innoviva Get Positive CHMP Opinion on Expanded COPD Indicati..
DJ
09/21ELI LILLY AND : Gets Positive CHMP Opinion for Migraine Drug Emgality
DJ
09/21AbbVie Gets Positive CHMP Opinion for Combination of Venclyxto With Rituximab..
DJ
09/21SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
09/20Animal health firm Elanco surges 41 percent on debut
RE
09/20WALL STREET STOCK EXCHANGE : Aurora Cannabis plans U.S. stock listing in October
RE
09/20ELI LILLY AND : Lilly Spinoff Elanco Animal Health Surges Early in Market Debut ..
DJ
09/20ONCOMED PHARMACEUTICALS : Says Celgene Won't Exercise Option to License Navicixi..
DJ
09/20PFIZER : 20vPnC Vaccine Gets FDA Breakthrough-Therapy Designation
DJ
09/20Nestle aims to shed skin unit to focus on food, nutrition
RE
09/20Nestle aims to shed skin unit to focus on food, nutrition
RE
09/20EU approves fifth copy of AbbVie's $18 billion drug Humira
RE
09/20BAYER : Levels Sights On Weedkiller Verdict
DJ
09/20SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
09/19ELI LILLY AND : IPO of Lilly Unit Elanco Animal Health Prices Above Range at $24
DJ
09/19BAYER : Steps Up Fight Over Weed Killer Blamed for Cancer - Update
DJ
09/19COCA COLA : moving ahead with takeover of Nigeria's Chi juice
RE
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug in First European Setback -..
DJ
09/19German chemical industry warns against disruptive no-deal Brexit
RE
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug for Some Patients Despite D..
DJ
09/19GILEAD SCIENCES : UK rejects adult Novartis CAR-T therapy, after 'yes' in kids
RE
09/19SHIRE : Rule 2.9 Announcement
DJ
09/19AstraZeneca plots China robot offensive to counter price cuts
RE
09/19AstraZeneca plots China robot offensive to counter price cuts
RE
09/19BAYER : Steps Up Legal Fight Over Weed Killer Blamed for Cancer
DJ
09/18ABBVIE : California Insurance Commissioner Sues AbbVie, Alleging 'Kickbacks' for..
DJ
09/18COCA COLA : buys Australia's kombucha maker Mojo
RE
09/18GLAXOSMITHKLINE : GSK grabs new drug development head from Boehringer
RE
09/18Aurora Cannabis Says No Current Deal on Partnership With Beverage Company
DJ
09/18COCA COLA : Aurora says no deal with beverage makers for weed-based drinks
RE
09/18Bayer says agriculture trade flows may change amid tariffs dispute
RE
09/18NOVO NORDISK A/S : Cuts 400 Jobs From R&D to Focus on New Pipeline
DJ
09/18NOVO NORDISK A/S : lays off 400 staff in research & development unit
RE
09/18Exclusive - India, U.S. closing in on package deal to remove trade irritants
RE
09/18SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
09/18REGENERON PHARMACEUTICALS : Sanofi pledges to keep up its restructuring efforts
RE
09/17NOVARTIS : links bonuses to ethics in bid to rebuild reputation
RE
09/17BAYER : Puts Controlling Stake in Currenta for Sale -Reuters
DJ
09/17Bayer puts stake in chemical park operator up for sale - sources
RE
09/17ASTRAZENECA : Three-Drug Combination Meets 8 out of 9 Objectives in COPD Trial
DJ
09/17SHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
09/15TEVA PHARMACEUTICAL INDUSTRIES : FDA Approves Teva's Migraine Drug Ajovy -- Upda..
DJ
09/14TEVA PHARMACEUTICAL INDUSTRIES : FDA Approves Teva's Migraine Drug Ajovy
DJ
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans
DJ
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans -- U..
DJ
1  2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2018 42 371 M
EBIT 2018 13 742 M
Net income 2018 7 016 M
Debt 2018 14 978 M
Yield 2018 2,74%
P/E ratio 2018 27,54
P/E ratio 2019 18,57
EV / Sales 2018 4,82x
EV / Sales 2019 4,57x
Capitalization 189 B
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
MERCK AND COMPANY25.79%189 092
JOHNSON & JOHNSON1.62%383 312
PFIZER21.65%258 285
NOVARTIS-0.63%216 108
ROCHE HOLDING LTD.-4.60%211 501
AMGEN17.94%132 756
ABBOTT LABORATORIES20.54%121 136
ELI LILLY AND COMPANY25.89%114 197
SANOFI3.69%109 540
BRISTOL-MYERS SQUIBB COMPANY0.77%101 584
GLAXOSMITHKLINE15.80%99 260
ASTRAZENECA10.72%92 763
NOVO NORDISK A/S-9.87%89 924
BAYER-25.23%83 828
ALLERGAN PLC17.69%64 939
CELGENE CORPORATION-15.39%61 699
SHIRE17.15%55 437
CHUGAI PHARMACEUTICAL CO LTD21.66%34 889
ASTELLAS PHARMA INC35.00%34 414
TAKEDA PHARMACEUTICAL CO LTD-27.49%33 259
JIANGSU HENGRUI MEDICINE CO LTD14.62%31 793